68 -- RNA LATER

The National Institutes of Health (NIH) National Institute of Child Health and Human Development (NICHD) has a requirement to purchase an RNAlater from Ambion Inc., 2130 Woodward Street, Ste, 200, Austin, TX 78744. To the best of the Government's knowledge Ambion is the only company that can offer this combination of manufacturing control, technical support, and packaging size of RNAlater that we require. Interested vendors may identify in writing their interest with a capability statement to the Contracting Office prior to the closing date of this notice. This notice of intent is not a request for competitive proposals, however, all responses received, before the closing date, of this announcement will be considered by the Government. A determination by the Government not to compete this proposed acquisition is based upon responses to this notice and is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. It is anticipated that the Request for Quotation (RFQ) NIH-NIDDK-06-755 will be available fifteen (15) days after the release of the RFQ. Receipt of quotations will be due ten (10) days after the release of the RFQ. The anticipated award date is April 7, 2006. Request for copies of the RFQ must be in writing to the National Institute of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Boulevard, Two Democracy Plaza, Room 774B, Bethesda, MD 20817 Attention: V. Lynn Griffin. FAX quotations must contain offerors name, address, telephone number and fax number. FAX quotations will be accepted if dated and signed by an authorized company representative. FAX NUMBER 301-480-8501.